AmputationNCT07865208
Measuring Plantar Pressures in Diabetic Patients With Lateral Forefoot Amputation
An observational study of Amputation and Diabetes Complications, run by Nanyang Technological University at 2 sites in Singapore.
Trial summary
This study aims to understand how pressure is placed on the bottom of the foot when people walk after a lateral forefoot amputation (for example, removal of the 5th toe). Podiatrists have noticed that people with this type of amputation often develop new foot wounds (ulcers) than other types of foot amputation. Read more about this study
- Who is it for?
- Ages 21 years and older
- Conditions the study is for
- Amputation, Diabetes Complications, Foot Complications
- How many people
- 70 participants
- Where
- 2 sitesSingapore
- Study dates
- 27 Nov 2026to 31 Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Tertiary Public Hospital
Who may be able to join
- Age ≥ 21 years
- Diagnosed with type 2 diabetes
- Presence of a healed unilateral lateral forefoot amputation (at least 5th MPJ, up to any level including the 2nd toe and 2nd ray)
- Ability to walk 10 meters unaided or with simple devices
- Of sound mind to communicate, follow instructions, and consent independently
- English or Chinese speaking
Who cannot join
- Amputation or partial amputation of the hallux and any bones higher than midfoot (cuneiforms, cuboid, navicular, calcaneus) on the affected foot
- Major lower limb amputation (above ankle), of other leg
- Severe gait impairments unrelated to foot amputation (stroke, foot drop etc)
- Other foot deforming disease such as, but not limited to, charcot neuroarthropathy, rheumatoid arthritis etc.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Singapore2 sites, 2 recruiting
- Recruiting
National University Hospital
Singapore, 119074
Xi Chen, Bachelor of Podiatry, +6589732316, chen_xi@nuhs.edu.sg
Vanessa Teo, Bachelor of Podiatry
- Recruiting
Ng Teng Fong General Hospital
Singapore, 609606
Xi Chen, Bachelor of Podiatry, +658973 2316, chen_xi@nuhs.edu.sg
About this study
Official title: Measuring Plantar Pressure Patterns in Diabetic Patients With Lateral Forefoot Amputations: a Cross-sectional Observational Study
This study aims to understand how pressure is placed on the bottom of the foot when people walk after a lateral forefoot amputation (for example, removal of the 5th toe).
Podiatrists have noticed that people with this type of amputation often develop new foot wounds (ulcers) than other types of foot amputation. By measuring foot pressure during walking, we hope to:
Read more
- Identify areas of high pressure ("hotspots")
- Understand walking patterns after amputation
- Identify biomechanical factors related to diabetic ulcers and foot amputations
- Design better footwear and insoles in the future based on this information
The hypothesis is that people with lateral forefoot amputation have higher plantar pressures on the remaining parts of their foot.
Read the detailed description
Diabetes mellitus (DM) imposes an escalating healthcare burden in Singapore, where diabetes-related amputation rates remain among the highest globally, and are continuing to increase. An index foot amputation often marks the beginning, rather than the end, of DM foot complications, where between 16-65% of patients undergo further amputation within five years. Notably there is a higher rate of reamputation associated with lateral ray/toes amputation compared to medial or other ray amputations (39% vs 25-27%), and as high as 60% of patients experience repeat ulceration after a 5th ray amputation. This suggests a very high risk of complications specifically associated with lateral ray amputations.
The lateral foot is essential for absorbing ground reaction forces, maintaining balance, and generating propulsion. Consequently, the loss of the lateral rays destabilizes the foot, leading to secondary foot deformities and increased peak plantar pressures (PPP) occurring at remaining metatarsal or midfoot regions. These mechanical shifts are the primary drivers of the "amputation cascade", associated with ulceration and infection and thereafter repeated amputations. Therefore, understanding pressure patterns in diabetes patients is critical for understanding factors contributing to further foot complications, and pave the way for developing strategies against it .
Gap in the literature Despite the biomechanical importance of the lateral ray and a high rate of complication, there is a distinct lack of empirical data regarding the biomechanical features of this specific group. It is also unclear why literature almost only exist for 1st ray and transmetatarsal amputations. Based on preliminary data extracted from diabetic foot management clinic in a Podiatry clinic in a tertiary hospital, there is approximately 25-30% of patients with lateral ray amputations that are undergoing active treatment for diabetic foot complications, forming a substantial proportion of patients and burden on the health system.
This study seeks to compare plantar pressure patterns of patients with such lateral ray amputations to those with intact feet. Complementing the existing data of medial ray and transmetatarsal amputation, we hope that results from this study can enable better identification of individuals at higher risk, guide targeted offloading, and enhance postoperative surveillance in the short term. Long term wise, the findings may inform risk stratification tools, support the incorporation of plantar pressure data into diabetic foot monitoring programmes, and improve efficiency in reducing ulcerations and healthcare burden.
MAIN AIMS
- To quantify the magnitude of peak pressure in diabetic individuals following lateral forefoot amputation compared to age-, BMI- and neuropathy matched diabetic controls with intact feet.
- To map the anatomical locations of peak pressure points following the loss of the lateral rays.
- To develop a pressure pattern classification system by identifying and quantifying the prevalence of specific loading phenotypes
METHODOLOGY This study will use a cross-sectional observational design involving individuals with diabetes who have a lateral forefoot amputation, compared to an age , BMI and neuropathy-matched diabetic control group without amputations. Lateral amputations will include at least 5th toe amputation up to 3rd ray resection. A small prospective look at the reulceration rates for both groups of people will also be noted for any association to plantar pressure values.
The total use of the participant's time will be about 3 hours. The participant may need to visit the hospital up to 2 times. All of the study procedures can be completed in the same day if the participant prefer.
Clinical evaluation for all participants:
- Age, sex
- Height, Weight, Body-mass index (BMI)
- Medical history, diabetes duration, HbA1c levels
- Presence of peripheral arterial disease
- Ulcer history (location, most recent recurrence)
- Neuropathy assessment (using 10g monofilament)
- Ankle, subtalar joint and midfoot joint range of motion measurements
- Identification of pre-ulcerative callus locations.
Published studies on partial foot amputations report small, heterogeneous samples without effect size reporting. However, based on the mean difference and standard deviation published in these studies on ray amputations, a 95% confidence level with anticipated small sample variability, and power analysis (alpha = 0.05, Power = 0.80), the minimum required sample size is approximately 35 participants per group for a total of 70 participants
Protocol:
Demonstration and practice runs will be provided to familiarize participants with the walkway to reduce "targeting" (altering gait to hit the sensor). Participants will perform the second-step protocol, which has been identified as the most efficient method for obtaining reliable plantar pressure data in diabetic populations. For participants in the amputation group, the foot with the lateral amputation will be tested; while the matched controls will test with their dominant foot for standardization. Due to sensor size limitations, one step will be captured per pass on the walkway. Participants will complete a round trip to the starting point after each step. Steps will be collected continuously until 5-6 valid footprints are recorded for the foot of study in each trial. If the subject shows obvious gait deviations, abnormalities or "targeting", the steps will be considered invalid and excluded from analysis. 3 trials will be taken for each participant as per the common research practice, to generate a single representative dataset for each participant.
During the trial, participants will walk at their self-selected natural gait speed. While higher speeds typically correlate with increased peak pressures, a natural pace is prioritized to ensure patient safety and represent "real-world" routine circumstances. Walking speed will be calculated via video analysis of a 1m calibrated zone. These recordings will also be used to check for step validity and to note any gait features needed to explain observations. If there is a significant difference in gait speed between groups, it will be included as a covariate in later analysis.
Data processing A mask is applied over the pressure profile to demarcate between the anatomical locations of interest, namely toes, metatarsals, midfoot and heel. Using the built-in software in the pressure mat, the peak pressure values will be obtained for each region of interest on the mask. The dependent variables at each of the regions of interest will be recorded down for each participant and each trial to be used for statistical analysis. The pressure heatmap and Center of pressure line will be generated automatically by the software.
To ensure the integrity of the matching process, Descriptive Statistics (medians and interquartile ranges) will be used to summarize participant characteristics. To confirm that the control and amputation groups are effectively matched, Mann-Whitney U tests will be performed on age, BMI, and neuropathy scores as the data is likely to be non-normally distributed. Should significant differences arise in baseline variables (assessed from clinical evaluation), for example with gait speed or BMI, these will be formally treated as covariates in the primary analysis to isolate the effect of the amputation.
Given the expected non-normal distribution of plantar pressure data, a Generalized Linear Model (GLM) will be employed for group comparisons. This model allows for the inclusion of amputation status as the primary predictor while statistically controlling for potential confounders such as gait speed and BMI. This ensures that observed pressure elevations are attributable to altered foot morphology rather than gait speed or systemic factors. To maintain statistical stringency due to multiple anatomical regions of interest, a statistical corrections will be applied to the significance threshold (p-value) to reduce type 1 error.
Visual analytics, including plantar pressure heatmaps and center of pressure lines, will be generated as pictures from the software. Based on the location of the highest mean peak pressure, each foot will be classified into a pattern type named with the location of the peak pressure in the mask. If there is more than one location of equally high peak pressure, then it will be classified into a combination type. The proportion of feet in each pattern type in each group can then be calculated with simple statistics. These will provide clinical context to the quantitative data, illustrating shifts in the progression of the pressure wave throughout the stance phase in the presence of lateral ray resections.
To explore the biomechanical compensations that may be associated with high pressure at certain locations, Spearman's Rank Correlation will be used to assess the association between joint range of motion and the location of peak pressure. This non-parametric approach is to determine if restricted joint mobility in the ankle or midfoot is associated with the presence of peak pressure points at the metatarsals or plantar styloid area.
- Keywords
- plantar pressure, amputation, diabetic, lateral ray amputation, reulceration, biomechanics, foot
- Medical subject headings
- Diabetes Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Amputee | 21 years old or older Type 2 Diabetes Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick) Healed amputation on one foot involving at least the 5th toe (and any other toes but excluding the big toe) | |
| Control | 21 years old or older Type 2 Diabetes no foot amputations Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Plantar pressure
- Peak plantar pressure (PPP), which indicates the highest pressure recorded within a single stance phase.
Measured: upon enrolment
Plantar pressure
Mean peak pressure - obtained by averaging the pressures across several steps
Measured: upon enrolment
Plantar pressure
Pressure-time integral (PTI) measures the cumulative pressure exerted on a specific location over the period of the stance phase
Measured: upon enrolment
Secondary outcomes (3)
Plantar pressure
Anatomical location of peak pressure based on pressure pattern heatmap (picture form)
Measured: upon enrolment
Plantar pressure
center of pressure line
Measured: upon enrolment
prospective reulceration rate
1-year reulceration rate
Measured: 1 year from enrolment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2026
- Study start27 Nov 2026 (estimated)
- Primary completionOct 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for AmputationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 70 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nanyang Technological University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Chen Xi, Nanyang Technological University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07865208
- Sponsor's protocol ID
- 2026-0037
- Status last verified
- Oct 2026
- First submitted
- 26 Sep 2026
- Last updated
- 8 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Institution policy disallow sharing of patient data outside of organisation. Only anonymised results for publishing are allowed
Publications
LeSavage LK, Hoffler HL, Evans JK, Blazek CD. Reulceration and Reoperation Rates After Central Ray Amputations: A Retrospective Study. J Foot Ankle Surg. 2023 May-Jun;62(3):482-486. doi: 10.1053/j.jfas.2022.11.014. Epub 2022 Nov 25.
PubMed 36543723Yammine K, Honeine M, Assi C. Should we resect more proximally? Outcomes of toe amputation versus ray resection in patients with infected diabetic ulcers and osteomyelitis. A preliminary study and new treatment algorithm. Foot Ankle Surg. 2023 Dec;29(8):593-596. doi: 10.1016/j.fas.2023.07.004. Epub 2023 Jul 17.
PubMed 37482478Lin JH, Jeon SY, Romano PS, Humphries MD. Rates and timing of subsequent amputation after initial minor amputation. J Vasc Surg. 2020 Jul;72(1):268-275. doi: 10.1016/j.jvs.2019.10.063. Epub 2020 Jan 21.
PubMed 31980248Izumi Y, Satterfield K, Lee S, Harkless LB. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care. 2006 Mar;29(3):566-70. doi: 10.2337/diacare.29.03.06.dc05-1992.
PubMed 16505507Cavanagh PR, Ulbrecht JS, Caputo GM. New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S6-S10. doi: 10.1002/1520-7560(200009/10)16:1+3.0.co;2-z.
PubMed 11054880Lockhart M, Dinneen SF, O'Keeffe DT. Plantar pressure measurement in diabetic foot disease: A scoping review. J Diabetes Investig. 2024 Aug;15(8):990-999. doi: 10.1111/jdi.14215. Epub 2024 Apr 18.
PubMed 38634342Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care. 1995 Nov;18(11):1460-2. doi: 10.2337/diacare.18.11.1460.
PubMed 8722070Elabd OM, El Nahass BG, Ibrahim MM. Pathological gait in partial foot amputation versus peripheral neuropathy. Gait Posture. 2023 Feb;100:41-48. doi: 10.1016/j.gaitpost.2022.11.064. Epub 2022 Dec 2.
PubMed 36481645Jarrett B, Cheung T, Oh E. The Lateral Column. Clin Podiatr Med Surg. 2020 Jan;37(1):53-60. doi: 10.1016/j.cpm.2019.08.005.
PubMed 31735269Hazari A, Maiya AG, Shivashankara KN, Agouris I, Monteiro A, Jadhav R, Kumar S, Shashi Kumar CG, Mayya SS. Kinetics and kinematics of diabetic foot in type 2 diabetes mellitus with and without peripheral neuropathy: a systematic review and meta-analysis. Springerplus. 2016 Oct 19;5(1):1819. doi: 10.1186/s40064-016-3405-9. eCollection 2016.
PubMed 27812455Borkosky SL, Roukis TS. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle. 2012;3. doi: 10.3402/dfa.v3i0.12169. Epub 2012 Jan 20.
PubMed 22396832Seckin MF, Ozcan C, Camur S, Polat O, Batar S. Predictive Factors and Amputation Level for Reamputation in Patients With Diabetic Foot: A Retrospective Case-Control Study. J Foot Ankle Surg. 2022 Jan-Feb;61(1):43-47. doi: 10.1053/j.jfas.2021.06.006. Epub 2021 Jun 19.
PubMed 34253432Wong KL, Nather A, Chanyarungrojn AP, Shen L, Ong TE, Elangovan RD, Lim CT. Clinical outcomes of ray amputation in diabetic foot patients. Ann Acad Med Singap. 2014 Aug;43(8):428-32. No abstract available.
PubMed 25244993Borg I, Mizzi S, Formosa C. Plantar Pressure Distribution in Patients with Diabetic Peripheral Neuropathy and a First-Ray Amputation. J Am Podiatr Med Assoc. 2018 May;108(3):225-230. doi: 10.7547/16-021.
PubMed 29932753
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measuring Plantar Pressure Patterns in Diabetic Patients With Lateral Forefoot Amputations: a Cross-sectional Observational Study
- ClinicalTrials.gov ID
- NCT07865208
- Acronym / sponsor ID
- 2026-0037
- Keywords
- plantar pressure, amputation, diabetic, lateral ray amputation, reulceration, biomechanics, foot
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 70 participants (estimated)
- Lead sponsor
- Nanyang Technological UniversityUniversity, hospital or other
- Study start
- 27 Nov 2026 (estimated)
- Primary completion
- Oct 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 8 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to understand how pressure is placed on the bottom of the foot when people walk after a lateral forefoot amputation (for example, removal of the 5th toe).
Podiatrists have noticed that people with this type of amputation often develop new foot wounds (ulcers) than other types of foot amputation. By measuring foot pressure during walking, we hope to:
- Identify areas of high pressure ("hotspots")
- Understand walking patterns after amputation
- Identify biomechanical factors related to diabetic ulcers and foot amputations
- Design better footwear and insoles in the future based on this information
The hypothesis is that people with lateral forefoot amputation have higher plantar pressures on the remaining parts of their foot.
Detailed description
Diabetes mellitus (DM) imposes an escalating healthcare burden in Singapore, where diabetes-related amputation rates remain among the highest globally, and are continuing to increase. An index foot amputation often marks the beginning, rather than the end, of DM foot complications, where between 16-65% of patients undergo further amputation within five years. Notably there is a higher rate of reamputation associated with lateral ray/toes amputation compared to medial or other ray amputations (39% vs 25-27%), and as high as 60% of patients experience repeat ulceration after a 5th ray amputation. This suggests a very high risk of complications specifically associated with lateral ray amputations.
The lateral foot is essential for absorbing ground reaction forces, maintaining balance, and generating propulsion. Consequently, the loss of the lateral rays destabilizes the foot, leading to secondary foot deformities and increased peak plantar pressures (PPP) occurring at remaining metatarsal or midfoot regions. These mechanical shifts are the primary drivers of the "amputation cascade", associated with ulceration and infection and thereafter repeated amputations. Therefore, understanding pressure patterns in diabetes patients is critical for understanding factors contributing to further foot complications, and pave the way for developing strategies against it .
Gap in the literature Despite the biomechanical importance of the lateral ray and a high rate of complication, there is a distinct lack of empirical data regarding the biomechanical features of this specific group. It is also unclear why literature almost only exist for 1st ray and transmetatarsal amputations. Based on preliminary data extracted from diabetic foot management clinic in a Podiatry clinic in a tertiary hospital, there is approximately 25-30% of patients with lateral ray amputations that are undergoing active treatment for diabetic foot complications, forming a substantial proportion of patients and burden on the health system.
This study seeks to compare plantar pressure patterns of patients with such lateral ray amputations to those with intact feet. Complementing the existing data of medial ray and transmetatarsal amputation, we hope that results from this study can enable better identification of individuals at higher risk, guide targeted offloading, and enhance postoperative surveillance in the short term. Long term wise, the findings may inform risk stratification tools, support the incorporation of plantar pressure data into diabetic foot monitoring programmes, and improve efficiency in reducing ulcerations and healthcare burden.
MAIN AIMS
- To quantify the magnitude of peak pressure in diabetic individuals following lateral forefoot amputation compared to age-, BMI- and neuropathy matched diabetic controls with intact feet.
- To map the anatomical locations of peak pressure points following the loss of the lateral rays.
- To develop a pressure pattern classification system by identifying and quantifying the prevalence of specific loading phenotypes
METHODOLOGY This study will use a cross-sectional observational design involving individuals with diabetes who have a lateral forefoot amputation, compared to an age , BMI and neuropathy-matched diabetic control group without amputations. Lateral amputations will include at least 5th toe amputation up to 3rd ray resection. A small prospective look at the reulceration rates for both groups of people will also be noted for any association to plantar pressure values.
The total use of the participant's time will be about 3 hours. The participant may need to visit the hospital up to 2 times. All of the study procedures can be completed in the same day if the participant prefer.
Clinical evaluation for all participants:
- Age, sex
- Height, Weight, Body-mass index (BMI)
- Medical history, diabetes duration, HbA1c levels
- Presence of peripheral arterial disease
- Ulcer history (location, most recent recurrence)
- Neuropathy assessment (using 10g monofilament)
- Ankle, subtalar joint and midfoot joint range of motion measurements
- Identification of pre-ulcerative callus locations.
Published studies on partial foot amputations report small, heterogeneous samples without effect size reporting. However, based on the mean difference and standard deviation published in these studies on ray amputations, a 95% confidence level with anticipated small sample variability, and power analysis (alpha = 0.05, Power = 0.80), the minimum required sample size is approximately 35 participants per group for a total of 70 participants
Protocol:
Demonstration and practice runs will be provided to familiarize participants with the walkway to reduce "targeting" (altering gait to hit the sensor). Participants will perform the second-step protocol, which has been identified as the most efficient method for obtaining reliable plantar pressure data in diabetic populations. For participants in the amputation group, the foot with the lateral amputation will be tested; while the matched controls will test with their dominant foot for standardization. Due to sensor size limitations, one step will be captured per pass on the walkway. Participants will complete a round trip to the starting point after each step. Steps will be collected continuously until 5-6 valid footprints are recorded for the foot of study in each trial. If the subject shows obvious gait deviations, abnormalities or "targeting", the steps will be considered invalid and excluded from analysis. 3 trials will be taken for each participant as per the common research practice, to generate a single representative dataset for each participant.
During the trial, participants will walk at their self-selected natural gait speed. While higher speeds typically correlate with increased peak pressures, a natural pace is prioritized to ensure patient safety and represent "real-world" routine circumstances. Walking speed will be calculated via video analysis of a 1m calibrated zone. These recordings will also be used to check for step validity and to note any gait features needed to explain observations. If there is a significant difference in gait speed between groups, it will be included as a covariate in later analysis.
Data processing A mask is applied over the pressure profile to demarcate between the anatomical locations of interest, namely toes, metatarsals, midfoot and heel. Using the built-in software in the pressure mat, the peak pressure values will be obtained for each region of interest on the mask. The dependent variables at each of the regions of interest will be recorded down for each participant and each trial to be used for statistical analysis. The pressure heatmap and Center of pressure line will be generated automatically by the software.
To ensure the integrity of the matching process, Descriptive Statistics (medians and interquartile ranges) will be used to summarize participant characteristics. To confirm that the control and amputation groups are effectively matched, Mann-Whitney U tests will be performed on age, BMI, and neuropathy scores as the data is likely to be non-normally distributed. Should significant differences arise in baseline variables (assessed from clinical evaluation), for example with gait speed or BMI, these will be formally treated as covariates in the primary analysis to isolate the effect of the amputation.
Given the expected non-normal distribution of plantar pressure data, a Generalized Linear Model (GLM) will be employed for group comparisons. This model allows for the inclusion of amputation status as the primary predictor while statistically controlling for potential confounders such as gait speed and BMI. This ensures that observed pressure elevations are attributable to altered foot morphology rather than gait speed or systemic factors. To maintain statistical stringency due to multiple anatomical regions of interest, a statistical corrections will be applied to the significance threshold (p-value) to reduce type 1 error.
Visual analytics, including plantar pressure heatmaps and center of pressure lines, will be generated as pictures from the software. Based on the location of the highest mean peak pressure, each foot will be classified into a pattern type named with the location of the peak pressure in the mask. If there is more than one location of equally high peak pressure, then it will be classified into a combination type. The proportion of feet in each pattern type in each group can then be calculated with simple statistics. These will provide clinical context to the quantitative data, illustrating shifts in the progression of the pressure wave throughout the stance phase in the presence of lateral ray resections.
To explore the biomechanical compensations that may be associated with high pressure at certain locations, Spearman's Rank Correlation will be used to assess the association between joint range of motion and the location of peak pressure. This non-parametric approach is to determine if restricted joint mobility in the ankle or midfoot is associated with the presence of peak pressure points at the metatarsals or plantar styloid area.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Amputee | – | –21 years old or older Type 2 Diabetes Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick) Healed amputation on one foot involving at least the 5th toe (and any other toes but excluding the big toe) |
| Control | – | –21 years old or older Type 2 Diabetes no foot amputations Able to walk 10 meters on your own, with or without a simple walking aid (such as a cane or walking stick) |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Tertiary Public Hospital
Key inclusion criteria (6 listed)
- Age ≥ 21 years
- Diagnosed with type 2 diabetes
- Presence of a healed unilateral lateral forefoot amputation (at least 5th MPJ, up to any level including the 2nd toe and 2nd ray)
- Ability to walk 10 meters unaided or with simple devices
- Of sound mind to communicate, follow instructions, and consent independently
Key exclusion criteria (4 listed)
- Amputation or partial amputation of the hallux and any bones higher than midfoot (cuneiforms, cuboid, navicular, calcaneus) on the affected foot
- Major lower limb amputation (above ankle), of other leg
- Severe gait impairments unrelated to foot amputation (stroke, foot drop etc)
- Other foot deforming disease such as, but not limited to, charcot neuroarthropathy, rheumatoid arthritis etc.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Plantar pressure
Time frame: upon enrolment
- Peak plantar pressure (PPP), which indicates the highest pressure recorded within a single stance phase.
Plantar pressure
Time frame: upon enrolment
Mean peak pressure - obtained by averaging the pressures across several steps
Plantar pressure
Time frame: upon enrolment
Pressure-time integral (PTI) measures the cumulative pressure exerted on a specific location over the period of the stance phase
3 secondary outcomes
Plantar pressure
Time frame: upon enrolment
Plantar pressure
Time frame: upon enrolment
prospective reulceration rate
Time frame: 1 year from enrolment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2026.
- Background: PubMed 36543723LeSavage LK, Hoffler HL, Evans JK, Blazek CD. Reulceration and Reoperation Rates After Central Ray Amputations: A Retrospective Study. J Foot Ankle Surg. 2023 May-Jun;62(3):482-486. doi: 10.1053/j.jfas.2022.11.014. Epub 2022 Nov 25.
- Background: PubMed 37482478Yammine K, Honeine M, Assi C. Should we resect more proximally? Outcomes of toe amputation versus ray resection in patients with infected diabetic ulcers and osteomyelitis. A preliminary study and new treatment algorithm. Foot Ankle Surg. 2023 Dec;29(8):593-596. doi: 10.1016/j.fas.2023.07.004. Epub 2023 Jul 17.
- Background: PubMed 31980248Lin JH, Jeon SY, Romano PS, Humphries MD. Rates and timing of subsequent amputation after initial minor amputation. J Vasc Surg. 2020 Jul;72(1):268-275. doi: 10.1016/j.jvs.2019.10.063. Epub 2020 Jan 21.
- Background: PubMed 16505507Izumi Y, Satterfield K, Lee S, Harkless LB. Risk of reamputation in diabetic patients stratified by limb and level of amputation: a 10-year observation. Diabetes Care. 2006 Mar;29(3):566-70. doi: 10.2337/diacare.29.03.06.dc05-1992.
- Background: PubMed 11054880Cavanagh PR, Ulbrecht JS, Caputo GM. New developments in the biomechanics of the diabetic foot. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S6-S10. doi: 10.1002/1520-7560(200009/10)16:1+3.0.co;2-z.
- Background: PubMed 38634342Lockhart M, Dinneen SF, O'Keeffe DT. Plantar pressure measurement in diabetic foot disease: A scoping review. J Diabetes Investig. 2024 Aug;15(8):990-999. doi: 10.1111/jdi.14215. Epub 2024 Apr 18.
- Background: PubMed 8722070Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care. 1995 Nov;18(11):1460-2. doi: 10.2337/diacare.18.11.1460.
- Background: PubMed 36481645Elabd OM, El Nahass BG, Ibrahim MM. Pathological gait in partial foot amputation versus peripheral neuropathy. Gait Posture. 2023 Feb;100:41-48. doi: 10.1016/j.gaitpost.2022.11.064. Epub 2022 Dec 2.
- Background: PubMed 31735269Jarrett B, Cheung T, Oh E. The Lateral Column. Clin Podiatr Med Surg. 2020 Jan;37(1):53-60. doi: 10.1016/j.cpm.2019.08.005.
- Background: PubMed 27812455Hazari A, Maiya AG, Shivashankara KN, Agouris I, Monteiro A, Jadhav R, Kumar S, Shashi Kumar CG, Mayya SS. Kinetics and kinematics of diabetic foot in type 2 diabetes mellitus with and without peripheral neuropathy: a systematic review and meta-analysis. Springerplus. 2016 Oct 19;5(1):1819. doi: 10.1186/s40064-016-3405-9. eCollection 2016.
- Background: PubMed 22396832Borkosky SL, Roukis TS. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle. 2012;3. doi: 10.3402/dfa.v3i0.12169. Epub 2012 Jan 20.
- Background: PubMed 34253432Seckin MF, Ozcan C, Camur S, Polat O, Batar S. Predictive Factors and Amputation Level for Reamputation in Patients With Diabetic Foot: A Retrospective Case-Control Study. J Foot Ankle Surg. 2022 Jan-Feb;61(1):43-47. doi: 10.1053/j.jfas.2021.06.006. Epub 2021 Jun 19.
- Individual participant dataSharing planned: No. Institution policy disallow sharing of patient data outside of organisation. Only anonymised results for publishing are allowed
Related trials for Amputation
RecruitingObservational study
Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain
Amputation, Amputation of Lower Limb
RecruitingObservational study
CNS Changes Following Upper Limb Loss
Amputation, Congenital, Upper Limb; Amelia
Recruiting
Hand Prosthesis Usability and Performance
Amputation
Recruiting
E-Socket, Diagnostic Monitoring
Trans-Tibial Amputation
RecruitingObservational study
Early Postoperative Pain Following a Limb Amputation
Amputation, Surgical, Pain Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Amputation and Diabetes Complications, run by Nanyang Technological University at 2 sites in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Xi Chen, Bachelor of Podiatry (+6589732316, chen_xi@nuhs.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Plantar pressure (time frame: upon enrolment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07865208, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.